Tasly Pharmaceutical Group Co Ltd Class A 600535
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 13.62
- Day Range
- CNY 13.32–13.61
- 52-Week Range
- CNY 12.88–18.00
- Bid/Ask
- CNY 13.37 / CNY 13.38
- Market Cap
- CNY 19.99 Bil
- Volume/Avg
- 14.5 Mil / 13.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 16.81
- Price/Sales
- 2.35
- Dividend Yield (Trailing)
- 2.39%
- Dividend Yield (Forward)
- 2.39%
- Total Yield
- 2.39%
Company Profile
Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 9,223
- Website
- http://www.tasly.com
Comparables
Valuation
|
Metric
|
600535
|
600216
|
600285
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.81 | 46.54 | 24.53 |
Price/Book Value | 1.61 | 0.96 | 4.93 |
Price/Sales | 2.35 | 1.17 | 4.20 |
Price/Cash Flow | 9.71 | 14.70 | 18.57 |
Price/Earnings
600535
600216
600285
Financial Strength
|
Metric
|
600535
|
600216
|
600285
|
|---|---|---|---|
Quick Ratio | 2.68 | 1.54 | 1.02 |
Current Ratio | 3.36 | 2.38 | 1.33 |
Interest Coverage | 14.58 | 13.45 | — |
Quick Ratio
600535
600216
600285
Profitability
|
Metric
|
600535
|
600216
|
600285
|
|---|---|---|---|
Return on Assets (Normalized) | 6.88% | 1.27% | 12.44% |
Return on Equity (Normalized) | 9.62% | 1.68% | 21.12% |
Return on Invested Capital (Normalized) | 7.44% | 1.59% | 19.26% |
Return on Assets
600535
600216
600285
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Nfgkyljqlj | Hzt | $81.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Slvvzpbmrv | Dwlybd | $80.4 Bil | |||
| Haleon PLC ADR
HLN
| Jsrvpnkp | Dszq | $37.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Dpwfppv | Wpn | $19.1 Bil | |||
| Viatris Inc
VTRS
| Lkszmxrcw | Nxbz | $12.7 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Bynphgnk | Thky | $12.0 Bil | |||
| Catalent Inc
CTLT
| Gyqyqfh | Gmnmvt | $10.1 Bil | |||
| Perrigo Co PLC
PRGO
| Qhrtcgbf | Hbn | $3.7 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Vgcqdhryl | Ghgggms | $3.3 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Kbzmxhs | Lrpfk | $3.2 Bil |